• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    US Stocks Mixed; Dell Posts Upbeat Results

    3/1/24 9:47:39 AM ET
    $ADIL
    $BIVI
    $DELL
    $FSR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADIL alert in real time by email

    U.S. stocks traded mixed this morning, with the Dow Jones falling around 40 points on Friday.

    Following the market opening Friday, the Dow traded down 0.11% to 38,954.76 while the NASDAQ rose 0.11% to 16,109.20. The S&P 500 also rose, gaining, 0.04% to 5,098.24.

    Check This Out: Robinhood, Shake Shack And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

     

    Energy shares rose by 1.1% on Friday.

    In trading on Friday, utilities shares fell by 1.1%.

     

    Top Headline

     

    Dell Technologies Inc. (NYSE:DELL) reported better-than-expected fourth-quarter financial results and increased its annual cash dividend by 20%.

     

    Equities Trading UP

     

    BioVie Inc. (NASDAQ:BIVI) shares shot up 126% to $2.80. BioVie's Ne3107 demonstrated potential improvements in motor and non-motor symptoms for Parkinson's disease patients and may be realigning physiological processes for Alzheimer's patients.

    Shares of Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) got a boost, surging 92% to $3.92. Adial Pharmaceuticals was awarded a new patent covering AD04 for the potential treatment of opioid use disorder.

    Nxu, Inc. (NASDAQ:NXU) shares were also up, gaining 39% to $1.11 after the company announced it successfully charged a Tesla Cybertruck on Feb. 26.

     

    Equities Trading DOWN

     

    GigCapital5, Inc. (NASDAQ:GIA) shares dropped 60% to $4.3999. GigCapital5 announced closing date of March 4, 2024 for business combination with QT Imaging.

    Shares of Fisker Inc. (NYSE:FSR) were down 48% to $0.38 after the company reported preliminary fourth-quarter total revenue results below estimates and said it expects to conclude there is substantial doubt about its ability to continue as a going concern when its annual financial statements are filed with the SEC.

    Scilex Holding Company (NASDAQ:SCLX) was down, falling 37% to $1.43 after reporting a $10 million bought deal offering.

    Also Check This Out: Top 3 Energy Stocks That Could Sink Your Portfolio In Q1

     

    Commodities

     

    In commodity news, oil traded up 1.7% to $79.55 while gold traded up 0.4% at $2,062.80.

    Silver traded rose 0.1% to $22.915 on Friday while copper fell 0.3% to $3.8355.

     

    Euro zone

     

    European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.4%, London’s FTSE 100 rose 0.7% while Spain’s IBEX 35 Index climbed 0.8% The German DAX gained 0.4% French CAC 40 fell 0.1% while Italy’s FTSE MIB Index surged 0.9%.

    The unemployment rate in the Eurozone fell to 6.4% in January from 6.5% in the previous month, while consumer price inflation rate eased to 2.6% year-over-year in February. The HCOB Eurozone manufacturing PMI was revised up to 46.5 in February versus a preliminary level of 46.1.

    The S&P Global UK manufacturing PMI was revised higher to 47.5 in February, recording the highest level in ten months, while German manufacturing PMI rose to 42.5 in February versus a preliminary level of 42.3. French manufacturing PMI rose to 47.1 in February versus a preliminary reading of 46.8.

     

    Asia Pacific Markets

     

    Asian markets closed higher on Friday, with Japan’s Nikkei 225 gaining 1.90%, Hong Kong’s Hang Seng Index climbing 0.47%, China’s Shanghai Composite Index gaining 0.39% and India’s S&P BSE Sensex gaining 1.72%.

    Retail sales in Hong Kong fell 1.2% year-over-year in January compared to a 4.8% increase in the prior month. The HSBC Indian manufacturing PMI climbed to 56.9 in February versus a preliminary level of 56.7.

    The official NBS manufacturing PMI in China fell to 49.1 in February from 49.2 a month ago, while official NBS non-manufacturing PMI rose to 51.4 from 50.7. The au Jibun Bank Japan manufacturing PMI fell to 47.2 in February from a final reading of 48.0 in January.

     

    Economics

     

    The ISM Manufacturing index will be released at 10:00 a.m. ET.

    Now Read This: Cramer Says This AI Stock Is Just An Nvidia Play, Prefers This Stock Over Anheuser-Busch

    Get the next $ADIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADIL
    $BIVI
    $DELL
    $FSR

    CompanyDatePrice TargetRatingAnalyst
    Dell Technologies Inc.
    $DELL
    4/9/2026Peer Perform
    Wolfe Research
    Dell Technologies Inc.
    $DELL
    3/31/2026$170.00Hold
    Truist
    Dell Technologies Inc.
    $DELL
    1/15/2026$148.00Equal Weight → Overweight
    Barclays
    Dell Technologies Inc.
    $DELL
    1/13/2026$165.00Buy
    Goldman
    Dell Technologies Inc.
    $DELL
    11/17/2025Overweight → Underweight
    Morgan Stanley
    Dell Technologies Inc.
    $DELL
    10/22/2025$172.00Overweight
    Piper Sandler
    Dell Technologies Inc.
    $DELL
    10/21/2025$152.00 → $161.00Outperform
    Raymond James
    Dell Technologies Inc.
    $DELL
    9/16/2025$175.00Outperform
    Bernstein
    More analyst ratings

    $ADIL
    $BIVI
    $DELL
    $FSR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial

    GLEN ALLEN, Va., April 22, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced the successful completion of the demonstration batch production for AD04. The results of the batch confirmed that the transferred process met the targeted specifications for the planned Phase 3 clinical batch (and registration campaign) and matched the dissolution profile of the previous Phase 2 batch, thereby demonstrating a successful technical process transfer. This important step was required prior to manufacturing

    4/22/26 9:35:00 AM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026

    PALO ALTO, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its Board of Directors (the "Scilex Board") approved a dividend of Dream Bowl I Meme Coin Tokens held by the Company (the "Dream Bowl Tokens") to its stockholders and certain other eligible equityholders of Scilex (collectively, the "Participating Holders"). The record date for the Dividend is April 30, 2026 (the "Record Date").

    4/20/26 9:00:00 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting

    CARSON CITY, Nev., April 14, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ:BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced the acceptance of an abstract from its SUNRISE-PD study on lead candidate bezisterim (NE3107) in the treatment of patients with Parkinson's Disease at the upcoming American Academy of Neurology Annual Meeting (AAN), to be held in Chicago, IL from April 18–22, 2026. The abstract, titled A Study of NE3107 (Bezisterim) in Early Parkinson's Disease (SUNRISE-PD): Baseline Demographics and Characteristic (J. Palumbo1, C Ahlem1, C.L. Reading1, S. O'Quinn2, J. Zhan

    4/14/26 8:00:00 AM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $BIVI
    $DELL
    $FSR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Do Cuong V bought 5,000 shares (SEC Form 4)

    4 - BIOVIE INC. (0001580149) (Issuer)

    8/13/25 4:05:17 PM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President Pratt Annie bought $15,246 worth of shares (61,733 units at $0.25), increasing direct ownership by 4% to 508,169 units (SEC Form 4)

    4 - Nxu, Inc. (0001722969) (Issuer)

    3/18/25 4:13:25 PM ET
    $NXU
    Construction/Ag Equipment/Trucks
    Consumer Discretionary

    Officer Shah Jaisim bought $13,800 worth of shares (30,000 units at $0.46), increasing direct ownership by 27% to 139,333 units (SEC Form 4)

    4 - Scilex Holding Co (0001820190) (Issuer)

    12/18/24 7:04:41 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADIL
    $BIVI
    $DELL
    $FSR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ma Stephen Hoi

    4 - Scilex Holding Co (0001820190) (Issuer)

    4/20/26 8:56:24 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Ji Henry

    4 - Scilex Holding Co (0001820190) (Issuer)

    4/20/26 8:52:50 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Slta V (Gp), L.L.C.

    4 - Dell Technologies Inc. (0001571996) (Issuer)

    4/17/26 4:39:50 PM ET
    $DELL
    Computer Manufacturing
    Technology

    $ADIL
    $BIVI
    $DELL
    $FSR
    SEC Filings

    View All

    Dell Technologies Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities

    8-K - Dell Technologies Inc. (0001571996) (Filer)

    4/20/26 4:20:27 PM ET
    $DELL
    Computer Manufacturing
    Technology

    SEC Form 144 filed by Dell Technologies Inc.

    144 - Dell Technologies Inc. (0001571996) (Subject)

    4/16/26 5:20:02 PM ET
    $DELL
    Computer Manufacturing
    Technology

    SEC Form S-3 filed by Scilex Holding Company

    S-3 - Scilex Holding Co (0001820190) (Filer)

    4/16/26 5:11:00 PM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADIL
    $BIVI
    $DELL
    $FSR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wolfe Research initiated coverage on Dell

    Wolfe Research initiated coverage of Dell with a rating of Peer Perform

    4/9/26 8:41:43 AM ET
    $DELL
    Computer Manufacturing
    Technology

    Truist initiated coverage on Dell with a new price target

    Truist initiated coverage of Dell with a rating of Hold and set a new price target of $170.00

    3/31/26 8:11:06 AM ET
    $DELL
    Computer Manufacturing
    Technology

    Dell upgraded by Barclays with a new price target

    Barclays upgraded Dell from Equal Weight to Overweight and set a new price target of $148.00

    1/15/26 8:27:45 AM ET
    $DELL
    Computer Manufacturing
    Technology

    $ADIL
    $BIVI
    $DELL
    $FSR
    Leadership Updates

    Live Leadership Updates

    View All

    Scilex Holding Company Appoints Kasowitz LLP as Litigation and Intellectual Property Counsel

    PALO ALTO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, announced that it has appointed Kasowitz LLP and its founding partner Marc Kasowitz as the Company's litigation and intellectual property counsel. Kasowitz LLP will advise Scilex on complex commercial litigation, patent litigation, intellectual property enforcement and defense, licensing matters, and strategic intellectual property governance as the C

    1/2/26 9:00:00 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Merlin Expands Executive Team Ahead of Public Listing

    Leslie Ravestein joins as Chief Legal Officer, David Lasater as Chief People Officer, and Pablo Gonzalez as Senior Vice President of Engineering Merlin Labs, Inc. ("Merlin"), a leading developer of assured, autonomous flight technology for defense customers, today announced key additions to its executive leadership team to optimize the organization in advance of its public listing via a Business Combination with Inflection Point Acquisition Corp. IV (NASDAQ:BACQ). The hires include two C-Suite additions, Leslie Ravestein as Chief Legal Officer and David Lasater as Chief People Officer, to strengthen corporate governance, drive operational excellence, and elevate talent strategy. Merlin al

    11/19/25 9:00:00 AM ET
    $AKAM
    $BACQ
    $DELL
    Real Estate
    Computer Manufacturing
    Technology
    Computer Software: Prepackaged Software

    BioVie Unveils Corporate Advisory Board Featuring Neuralink Co-Founder, Former Executives from Mastercard and Apple, and High-Impact Industry Leaders to Advance BioVie Mission and Growth

    The seven-member Board includes Cedars-Sinai brain health leader Dr. Zaldy Tan, Parkwood marketing powerhouse Justina Omokhua, and Neuralink visionary Tim Gardner Each Board member brings deep personal conviction and cross-sector expertise to unlock value and reshape care in Alzheimer's, Parkinson's and other neuroinflammatory disorders CARSON CITY, Nev., May 05, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ:BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced the formation of its Corporate Advisory Board – a coalition of seven powerhous

    5/5/25 8:00:00 AM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $BIVI
    $DELL
    $FSR
    Financials

    Live finance-specific insights

    View All

    Scilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026

    PALO ALTO, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its Board of Directors (the "Scilex Board") approved a dividend of Dream Bowl I Meme Coin Tokens held by the Company (the "Dream Bowl Tokens") to its stockholders and certain other eligible equityholders of Scilex (collectively, the "Participating Holders"). The record date for the Dividend is April 30, 2026 (the "Record Date").

    4/20/26 9:00:00 AM ET
    $SCLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Dell Technologies Declares Quarterly Cash Dividend

    Dell Technologies (NYSE:DELL) announces that its board of directors has declared a quarterly cash dividend of $0.63 per common share, which will be payable on May 1 to shareholders of record as of Apr. 21. About Dell Technologies Dell Technologies (NYSE:DELL) helps organizations and individuals build their digital future and transform how they work, live and play. The company provides customers with the industry's broadest and most innovative technology and services portfolio for the AI era. Copyright © 2026 Dell Inc. or its subsidiaries. All Rights Reserved. Dell Technologies, Dell, EMC and Dell EMC are trademarks of Dell Inc. or its subsidiaries. Other trademarks may be trademarks o

    3/2/26 8:30:00 AM ET
    $DELL
    Computer Manufacturing
    Technology

    Dell Technologies Delivers Fourth Quarter and Full-Year Fiscal 2026 Results

    Dell Technologies (NYSE:DELL) announces financial results for its fiscal 2026 fourth quarter and full year ended January 30, 2026. The company also provides guidance for its fiscal 2027 first quarter and full year. Full-Year Summary Record full-year revenue of $113.5 billion, up 19% year over year Record full-year diluted earnings per share (EPS) of $8.68, up 36% year over year, and record full-year non-GAAP diluted EPS of $10.30, up 27% Record full-year cash flow from operations of $11.2 billion Announcing a cash dividend increase of 20% and $10 billion increase in share repurchase authorization FY27 guidance: Full-year revenue growth of 23% at the midpoint, diluted EPS gr

    2/26/26 4:05:00 PM ET
    $DELL
    Computer Manufacturing
    Technology

    $ADIL
    $BIVI
    $DELL
    $FSR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Adial Pharmaceuticals Inc

    SC 13G/A - ADIAL PHARMACEUTICALS, INC. (0001513525) (Subject)

    11/14/24 3:44:01 PM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Dell Technologies Inc.

    SC 13G/A - Dell Technologies Inc. (0001571996) (Subject)

    11/12/24 4:40:00 PM ET
    $DELL
    Computer Manufacturing
    Technology

    Amendment: SEC Form SC 13G/A filed by Dell Technologies Inc.

    SC 13G/A - Dell Technologies Inc. (0001571996) (Subject)

    11/12/24 2:29:00 PM ET
    $DELL
    Computer Manufacturing
    Technology